Nucleic Acid Therapeutics Market Size, Share, Growth Analysis, By Technology(Anti-sense and Anti-gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs), By Application(Monogenetic Disorders, Thalassemia, Sickle Cell Anemia, Hemophilia), By Surgery(Hospitals and Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Q: What is the global market size of Nucleic Acid Therapeutics Market?

Global Nucleic Acid Therapeutics Market size was valued at USD 12.08 Billion in 2022 and is poised to grow from USD 12.57 Billion in 2023 to USD 17.34 Billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

Q: Who are the key vendors in the Global Nucleic Acid Therapeutics Market?

The competitive environment of the Global Nucleic Acid Therapeutics Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'agtc', 'Wave Life Science Ltd.', 'Imugene', 'Aileron Therapeutics Inc.', 'Akcea Therapeutics', 'BioNTech SE', 'Biocon', 'Biomedica', 'Protagonist Therapeutics Inc.', 'Replicate Bioscience Inc.', 'Eli Lily and Company', 'Copernicus Therapeutics Inc.', 'Invio Pharmaceuticals Inc.', 'Benitec Biopharma', 'Alnylam Pharmaceuticals', 'Zydus Cadila', 'Excision BioTherapeutics', 'Pfizer Inc.', 'Rhythm Pharmaceuticals Inc.', 'Axcella Health Inc.'.

Report ID: SQMIG35A2868 | Region: Global | Published Date: April, 2024
Pages: 210 | Tables: 100 | Figures: 76

Nucleic Acid Therapeutics Market News

August 2022 Merck & Co. and Orna Therapeutics, Inc. will develop and commercialize a new class of therapeutic RNAs for the treatment of infectious cancers.

January 2022 The bivalent modified COVID-19 vaccine for Omicron BA.4/BA.5 will begin clinical trials, according to Pfizer Inc. and Biontech SE shows.

American biotechnology company Ionis Pharmaceuticals, Inc. reported in January 2022 that tofersen, an experimental antipsychotic drug for the treatment of superoxide dismutase one amyotrophic lateral sclerosis, received FDA approval (SOD1-ALS).

Nucleic Acid Therapeutics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nucleic Acid Therapeutics Market size was valued at USD 12.08 Billion in 2022 and is poised to grow from USD 12.57 Billion in 2023 to USD 17.34 Billion by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

The competitive environment of the Nucleic Acid Therapeutics Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'agtc', 'Wave Life Science Ltd.', 'Imugene', 'Aileron Therapeutics Inc.', 'Akcea Therapeutics', 'BioNTech SE', 'Biocon', 'Biomedica', 'Protagonist Therapeutics Inc.', 'Replicate Bioscience Inc.', 'Eli Lily and Company', 'Copernicus Therapeutics Inc.', 'Invio Pharmaceuticals Inc.', 'Benitec Biopharma', 'Alnylam Pharmaceuticals', 'Zydus Cadila', 'Excision BioTherapeutics', 'Pfizer Inc.', 'Rhythm Pharmaceuticals Inc.', 'Axcella Health Inc.'

Advances in molecular technologies and ongoing research on omics have led many companies to invest heavily in it. The nucleic acid-based therapeutics market is highly competitive and market share is gained through multiple business strategies. Acquisitions, partnerships or collaborations are key sources of revenue in the marketplace. For example, in August 2022, Merck & Co. will launch a $1. announced a new therapeutic RNA collaboration with Orna Therapeutics. This collaboration includes the discovery, development and commercialization of novel RNA-based therapies for vaccines, infectious diseases, and oncology programs.

Increased Investment in Healthcare Services to Increase Market Growth: Increased investment in healthcare has also accelerated the pace of research into many diseases and illnesses. Research efforts to improve health facilities have increased due to the increasing prevalence of genetic abnormalities and chronic diseases in the population.

North America is predicted to lead the market owing to factors such as high prevalence of chronic diseases such as cancer and diabetes, growing availability of targeted and customized drugs, and supportive government efforts, according to January 2022 CDC National Diabetes Statistical Report More than 130 shows it people in the United States have diabetes. The United States dominates the North American markets.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Nucleic Acid Therapeutics Market News

Nucleic Acid Therapeutics Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Nucleic Acid Therapeutics Market?

Who are the key vendors in the Nucleic Acid Therapeutics Market?

What is the key driver of Nucleic Acid Therapeutics Market?

What is the key market trend for Nucleic Acid Therapeutics Market?

Which region accounted for the largest share in Nucleic Acid Therapeutics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300